Literature DB >> 34249593

MicroRNA-199-3p targets Sp1 transcription factor to regulate proliferation and epithelial to mesenchymal transition of human lung cancer cells.

Jiajia Fu1, Tong Li2, Xiaozhen Jiang3, Bin Xia1, Lijuan Hu4.   

Abstract

The present study was undertaken to study the function of miRNA-199-3p in the regulation of human lung cancer growth and metastasis. The results showed significant (P < 0.05) downregulation of miRNA-199-3p in lung cancer tissues and cell lines. Overexpression of miR-197 caused considerable inhibition of the viability and colony formation of the lung cancer cells. The inhibition of proliferation was found to be due to the arrest of the SK-LU-1 lung cancer cells. At the G2/M phase of the cell cycle. In silico analysis and subsequent the dual-luciferase assays showed that miR-199-3p targets Sp1 at molecular. The expression of Sp1 was significantly (P < 0.05) upregulated in lung cancer cells and tissues. Nonetheless, miR-199-3p overexpression could cause post-transcriptional suppression of Sp1. Silencing of Sp1suppress the proliferation of SK-LU-1 lung cancer cells. However, overexpression Sp1 transcription factor prevents the tumor-suppressive effects of miR-199-3p on lung cancer cells. Additionally, miR-199-3p was found to suppresses the migration, invasion and epithelial-to-mesenchymal transition of human lung cancer cells. Summing up, miRNA-199-3p/SP1 axis controls the growth and metastasis of SK-LU-1 lung cancer cells. © King Abdulaziz City for Science and Technology 2021.

Entities:  

Keywords:  Epithelial-to-mesenchymal transition; Lung cancer; Micro-RNA; Post-transcriptional silencing; SP1 transcription factor; miRNA-199-3p

Year:  2021        PMID: 34249593      PMCID: PMC8219823          DOI: 10.1007/s13205-021-02881-x

Source DB:  PubMed          Journal:  3 Biotech        ISSN: 2190-5738            Impact factor:   2.893


  29 in total

Review 1.  Sp1 and the 'hallmarks of cancer'.

Authors:  Kate Beishline; Jane Azizkhan-Clifford
Journal:  FEBS J       Date:  2015-01-08       Impact factor: 5.542

2.  Antineoplastic Treatment of Advanced-Stage Non-Small-Cell Lung Cancer: Treatment, Survival, and Spending (2000 to 2011).

Authors:  Cathy J Bradley; K Robin Yabroff; Angela B Mariotto; Christopher Zeruto; Quyen Tran; Joan L Warren
Journal:  J Clin Oncol       Date:  2017-01-03       Impact factor: 44.544

Review 3.  MicroRNAs in learning, memory, and neurological diseases.

Authors:  Wenyuan Wang; Ester J Kwon; Li-Huei Tsai
Journal:  Learn Mem       Date:  2012-08-16       Impact factor: 2.460

4.  Cancer treatment and survivorship statistics, 2019.

Authors:  Kimberly D Miller; Leticia Nogueira; Angela B Mariotto; Julia H Rowland; K Robin Yabroff; Catherine M Alfano; Ahmedin Jemal; Joan L Kramer; Rebecca L Siegel
Journal:  CA Cancer J Clin       Date:  2019-06-11       Impact factor: 508.702

Review 5.  Risk factors of Lung Cancer in nonsmoker.

Authors:  Nahid Akhtar; Jeena Gupta Bansal
Journal:  Curr Probl Cancer       Date:  2017-07-27       Impact factor: 3.187

Review 6.  Exosomal miRNAs as novel cancer biomarkers: Challenges and opportunities.

Authors:  Mahsa Salehi; Mohammadreza Sharifi
Journal:  J Cell Physiol       Date:  2018-03-25       Impact factor: 6.384

7.  Lung Cancer: A Wily Genetic Opponent.

Authors:  Peggy P Hsu; Alice T Shaw
Journal:  Cell       Date:  2017-05-18       Impact factor: 41.582

8.  MiR-199a-3p promotes gastric cancer progression by targeting ZHX1.

Authors:  Zhenqiang Wang; Xingjie Ma; Qiang Cai; Xinjing Wang; Beiqin Yu; Qu Cai; Bingya liu; Zhenggang Zhu; Chen Li
Journal:  FEBS Lett       Date:  2014-11-28       Impact factor: 4.124

Review 9.  MicroRNAs in metabolic disease.

Authors:  Carlos Fernández-Hernando; Cristina M Ramírez; Leigh Goedeke; Yajaira Suárez
Journal:  Arterioscler Thromb Vasc Biol       Date:  2013-02       Impact factor: 8.311

10.  ZEB1 drives epithelial-to-mesenchymal transition in lung cancer.

Authors:  Jill E Larsen; Vaishnavi Nathan; Jihan K Osborne; Rebecca K Farrow; Dhruba Deb; James P Sullivan; Patrick D Dospoy; Alexander Augustyn; Suzie K Hight; Mitsuo Sato; Luc Girard; Carmen Behrens; Ignacio I Wistuba; Adi F Gazdar; Nicholas K Hayward; John D Minna
Journal:  J Clin Invest       Date:  2016-08-08       Impact factor: 14.808

View more
  1 in total

1.  Global Noncoding microRNA Profiling in Mice Infected with Partial Human Mouth Microbes (PAHMM) Using an Ecological Time-Sequential Polybacterial Periodontal Infection (ETSPPI) Model Reveals Sex-Specific Differential microRNA Expression.

Authors:  Chairmandurai Aravindraja; Matteen R Kashef; Krishna Mukesh Vekariya; Ravi K Ghanta; Shama Karanth; Edward K L Chan; Lakshmyya Kesavalu
Journal:  Int J Mol Sci       Date:  2022-05-04       Impact factor: 6.208

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.